Apyx Medical (APYX) Income from Continuing Operations (2011 - 2026)

Apyx Medical has reported Income from Continuing Operations for 16 years, with the latest figure at 2143000.0 in Q1 2026.

• For the quarter ending Q1 2026, Income from Continuing Operations rose 48.63% year-over-year to 2143000.0; the trailing twelve-month figure through Mar 2026 stood at 4779000.0 (down 14.98% YoY), and the FY2025 full-year result was 2750000.0, up 24.83% from the prior year.
• Income from Continuing Operations for Q1 2026 stood at 2143000.0, down from 12615000.0 in the prior quarter.
• The five-year high for Income from Continuing Operations was 21103000.0 in Q4 2024, with the low at 9624000.0 in Q4 2023.
• Historically, Income from Continuing Operations has averaged 2312823.53 across 5 years, with a median of 4675000.0 in 2023.
• The largest YoY upside for Income from Continuing Operations was 319.27% in 2024 against a maximum downside of 546.32% in 2024.
• Apyx Medical's Income from Continuing Operations stood at 6065000.0 in 2022, then sank by 58.68% to 9624000.0 in 2023, then soared by 319.27% to 21103000.0 in 2024, then sank by 40.22% to 12615000.0 in 2025, then plunged by 116.99% to 2143000.0 in 2026.
• The last three Income from Continuing Operations figures came in at 2143000.0 (Q1 2026), 12615000.0 (Q4 2025), and 1955000.0 (Q3 2025), per Business Quant data.